Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley S Davis

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|January 28, 2003
Parenteral polymersStanley S Davis
Drug Discovery Today|February 15, 2005
Formulation strategies for absorption windowsStanley S Davis
Vaccine|July 11, 2006
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal deliveryStanley S Davis
Clinical Pharmacokinetics|October 9, 2003
Absorption enhancers for nasal drug deliveryStanley S Davis, Lisbeth Illum
Drug Development and Industrial Pharmacy|October 27, 2007
Design and evaluation of an emulsion vehicle for paclitaxel. II. Suppression of the crystallization of paclitaxel by freeze-drying techniqueJihong Han, Clive Washington, Stanley S Davis
Pharmaceutical Research|January 20, 2006
Advances in the use of tocols as drug delivery vehiclesPanayiotis P Constantinides, Jihong Han, Stanley S Davis
Journal of Drug Targeting|June 2, 2007
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous systemStuart T Charlton, Stanley S Davis, Lisbeth Illum
Pharmaceutical Research|October 23, 2004
Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stabilityJihong Han, Stanley S Davis, Catherine Papandreou, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Development of multicomponent DNA delivery systems based upon poly(amidoamine)-PEG co-polymersBenjamin J Rackstraw, Snjezana Stolnik, Stanley S Davis, et al.
International Journal of Pharmaceutics|November 14, 2002
The effect of ileal brake activators on the oral bioavailability of atenolol in manClair L Dobson, Stanley S Davis, Sushil Chauhan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|January 28, 2003
Parenteral polymersStanley S Davis
Drug Discovery Today|February 15, 2005
Formulation strategies for absorption windowsStanley S Davis
Vaccine|July 11, 2006
The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal deliveryStanley S Davis
Clinical Pharmacokinetics|October 9, 2003
Absorption enhancers for nasal drug deliveryStanley S Davis, Lisbeth Illum
Drug Development and Industrial Pharmacy|October 27, 2007
Design and evaluation of an emulsion vehicle for paclitaxel. II. Suppression of the crystallization of paclitaxel by freeze-drying techniqueJihong Han, Clive Washington, Stanley S Davis
Pharmaceutical Research|January 20, 2006
Advances in the use of tocols as drug delivery vehiclesPanayiotis P Constantinides, Jihong Han, Stanley S Davis
Journal of Drug Targeting|June 2, 2007
Evaluation of effect of ephedrine on the transport of drugs from the nasal cavity to the systemic circulation and the central nervous systemStuart T Charlton, Stanley S Davis, Lisbeth Illum
Pharmaceutical Research|October 23, 2004
Design and evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stabilityJihong Han, Stanley S Davis, Catherine Papandreou, et al.
Biochimica Et Biophysica Acta|June 27, 2002
Development of multicomponent DNA delivery systems based upon poly(amidoamine)-PEG co-polymersBenjamin J Rackstraw, Snjezana Stolnik, Stanley S Davis, et al.
International Journal of Pharmaceutics|November 14, 2002
The effect of ileal brake activators on the oral bioavailability of atenolol in manClair L Dobson, Stanley S Davis, Sushil Chauhan, et al.
Pageof 2